financetom
Business
financetom
/
Business
/
KKR considering selling Japan's Seiyu supermarket, Nikkei says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR considering selling Japan's Seiyu supermarket, Nikkei says
Jan 6, 2025 8:09 PM

TOKYO, Jan 7 (Reuters) - U.S. private equity fund KKR

is considering selling supermarket chain Seiyu in a deal

that could worth several hundred billion yen (several billion

dollars), the Nikkei business daily reported on Tuesday.

The bidding process for the sale of shares has begun, and

major retailers including Aeon, Don Quijote owner Pan

Pacific International Holdings ( DQJCF ) and Trial Holdings

, as well as an investment fund or funds have submitted

bids, Nikkei said without citing sources.

KKR owns 85% of Seiyu and Walmart ( WMT ) the remaining 15%.

The Nikkei said Walmart's ( WMT ) stake was also likely to be sold, and

that the final buyer would be decided by around February, the

newspaper reported.

KKR declined to comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pliant Therapeutics Signs Shareholder Rights Agreement
Pliant Therapeutics Signs Shareholder Rights Agreement
Mar 13, 2025
08:31 AM EDT, 03/13/2025 (MT Newswires) -- Pliant Therapeutics ( PLRX ) said Thursday that its board of directors has approved a limited duration shareholder rights agreement. The company said the move is in response to recent open market accumulation of its common stock and is intended to prevent any attempt to gain control of the company without its approval....
Vir Biotechnology Enrolls First Patient in Phase 3 Chronic Hepatitis Delta Trial
Vir Biotechnology Enrolls First Patient in Phase 3 Chronic Hepatitis Delta Trial
Mar 13, 2025
08:29 AM EDT, 03/13/2025 (MT Newswires) -- Vir Biotechnology ( VIR ) said Thursday it has enrolled the first patient in a phase 3 study that will evaluate the efficacy and safety of its drug tobevibart in combination with elebsiran as a potential treatment for chronic hepatitis delta. The trial is designed to provide the registrational data for submission to...
Medical Facilities Q4 Profit Jumps
Medical Facilities Q4 Profit Jumps
Mar 13, 2025
08:30 AM EDT, 03/13/2025 (MT Newswires) -- Medical Facilities ( MFCSF ) on Thursday reported a jump in fourth-quarter profit. The company, which partners with physicians and owns a portfolio of surgical facilities in the U.S., said profit surged 158% to US$36 million, or US$0.59 per diluted share, from US$14 million, or US$0.29 per diluted share, in the previous corresponding...
XWELL Plans to Acquire Medical Spas as Part of Expansion into Wellness, Beauty Sector
XWELL Plans to Acquire Medical Spas as Part of Expansion into Wellness, Beauty Sector
Mar 13, 2025
08:32 AM EDT, 03/13/2025 (MT Newswires) -- XWELL ( XWEL ) said Thursday it plans to acquire select medical spas by the end of 2025, using its recent $4 million private placement to enter the high-growth wellness and beauty market. The company said the move would extend its services beyond airports into metropolitan areas with rising demand for advanced beauty...
Copyright 2023-2026 - www.financetom.com All Rights Reserved